[SCHEDULE 13G] NovoCure Limited SEC Filing

Rhea-AI Filing Summary

Capital World Investors (CWI) reports beneficial ownership of 6,382,848 shares of NovoCure Ltd. common stock, representing 5.7% of the 111,485,634 shares believed outstanding. CWI is identified as an investment adviser division of Capital Research and Management Company and related entities that provide investment management services under the name "Capital World Investors." The filing states CWI has sole voting and sole dispositive power over all 6,382,848 shares and that the holdings are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Positive

• Material disclosure: CWI holds 6,382,848 shares, representing a clear 5.7% stake above SEC reporting thresholds.
• Sole authority: The filer reports sole voting and sole dispositive power over all disclosed shares, which provides clarity on who controls voting decisions for that stake.
• Passive intent certified: The filing includes a certification that the shares are held in the ordinary course of business and not to influence control of the issuer.

Negative

• None.

Insights

Securities Analyst

TL;DR: A passive institutional stake of 5.7% is material but filed as non-control; voting and dispositive power are held solely by CWI.

The Schedule 13G disclosure shows an institutional investor crossing the 5% reporting threshold with 6.38 million shares, which is large enough to be material for shareholders and analysts monitoring ownership concentration. Because the filing is on Schedule 13G and includes the certification that shares are held in the ordinary course and not to influence control, the position should be treated as a passive investment rather than an activist or control-seeking stake. Sole voting and dispositive power signals centralized decision authority within the reporting entity, which is relevant for tracking potential future trading activity.

Corporate Governance Expert

TL;DR: Material disclosure of a >5% passive holding; governance impact limited because filer disclaims intent to influence control.

The report identifies Capital World Investors as an investment adviser-type reporting person with full voting and dispositive authority over the disclosed shares. From a governance perspective, a 5.7% holder merits monitoring because such stakes can affect shareholder votes or signal institutional sentiment, but the filing expressly states the position is not intended to change control. Stake concentration and sole authority over votes are factual items investors and boards should note for proxy and engagement considerations.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

NovoCure Ltd.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

G6674U108

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. G6674U108

1

Names of Reporting Persons

Capital World Investors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 6,382,848.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 6,382,848.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

6,382,848.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.7 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: NovoCure Ltd.
(b)	Address of issuer's principal executive offices: NO. 4 The Forum, Grenville Street, St. Helier JE2 4UF, Jersey
Item 2.
(a)	Name of person filing: Capital World Investors
(b)	Address or principal business office or, if none, residence: 333 SOUTH HOPE STREET, 55TH FLOOR, LOS ANGELES, CALIFORNIA 90071
(c)	Citizenship: N/A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: G6674U108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 6,382,848 ** **Capital World Investors ("CWI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CWI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital World Investors." CWI is deemed to be the beneficial owner of 6,382,848 shares or 5.7% of the 111,485,634 shares believed to be outstanding.
(b)	Percent of class: 5.7 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 6,382,848
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 6,382,848
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capital World Investors

Signature:	Timothy J. Moon
Name/Title:	Vice President and Senior Counsel, Capital Research and Management Company
Date:	08/04/2025

FAQ

How many NovoCure (NVCR) shares does Capital World Investors own?

Capital World Investors beneficially owns 6,382,848 shares of NovoCure common stock.

What percentage of NVCR does CWI's holding represent?

The holding represents 5.7% of the 111,485,634 shares believed to be outstanding, as stated in the filing.

Does CWI have voting power over the NVCR shares it reports?

Yes. The filing reports sole voting power of 6,382,848 shares and sole dispositive power of 6,382,848 shares.

Is the CWI stake intended to change or influence control of NovoCure?

No. The certification states the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer.

What type of reporting person is Capital World Investors?

The filing identifies Capital World Investors as an investment adviser (IA)-type reporting person.